Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 27;16(1):481.
doi: 10.1186/s13256-022-03713-z.

Prenatal diagnosis of distal 13q deletion syndrome in a fetus with esophageal atresia: a case report and review of the literature

Affiliations
Review

Prenatal diagnosis of distal 13q deletion syndrome in a fetus with esophageal atresia: a case report and review of the literature

Tomomi Kotani et al. J Med Case Rep. .

Abstract

Background: Chromosome 13q deletion syndrome shows variable clinical features related to the different potential breakpoints in chromosome 13q. The severely malformed phenotype is known to be associated with the deletion of a critical region in 13q32. However, esophageal atresia is a rare symptom and the relevant region is unknown. Thus, determining the association between accurate breakpoints and new clinical features is essential.

Case presentation: A 28-year-old Japanese primigravid woman was referred for fetal growth restriction, absence of a gastric bubble, cerebellar hypoplasia, overlapping fingers, and polyhydramnios at 31 weeks gestation. At 38 + 0 weeks, she delivered a 1774 g female infant. The infant presented with isolated esophageal atresia (Gross type A), Dandy-Walker malformation, right microphthalmia, left coloboma, overlapping fingers, pleurocentrum in the thoracic vertebrae, reduced anogenital distance, and hearing loss. Her karyotype was diagnosed as 46,XX,del(13)(q32.1-qter) by amniocentesis, but array comparative genomic hybridization after birth revealed the deletion of 13q31.3-qter. At 48 days after birth, the infant underwent surgery for esophageal atresia and was later discharged from the hospital at 7 months of age.

Conclusion: This case report and the literature reviews supports the previous findings on the pathological roles of haploinsufficiency of the ZIC2/ZIC5 in Dandy-Walker malformation and the EFBN2 haploinsufficiency in eye malformation and hearing loss. Furthermore, the possible involvement of IRS2, COLA1, and COLA2 in eye malformation were identified. This is the first case of 13q deletion syndrome with esophageal atresia (Gross A), but it may be a symptom of VATER/VACTER association (vertebral defects, anorectal malformations, cardiac defects, tracheoesophageal fistula with or without esophageal atresia, renal malformations, and limb defects), as in the previous cases. These symptoms might also be associated with EFBN2 haploinsufficiency, although further research is required.

Keywords: Array comparative genomic hybridization; Esophageal atresia; Prenatal diagnosis.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interest to declare.

Figures

Fig. 1
Fig. 1
Fetal magnetic resonance imaging scans. Sagittal (a) and axial (b) views at 34 weeks of gestation. Arrows indicate the cerebellum
Fig. 2
Fig. 2
Chromosomal analyses. a Results of Giemsa banding by amniocentesis. The arrow indicates the abnormal chromosome 13, as del(13)(q32.1). b The result of fluorescent in situ hybridization by amniocentesis. The normal chromosome 13 had both 13q14 (blue) and 13qter (yellow), but no signal indicative of 13qter was detected on the chromosome del(13)(q32.1). c Array CGH analysis reveals the deleted region of 13q31.2–qter (92973314–115097664). The right panel shows an enlarged view of the gene deletion site in the left panel
Fig. 3
Fig. 3
Candidate genes are related to the phenotype of the present patient. The red line shows the deleted region of the present patient. The numbers shown in the parentheses are consistent with the reference numbers

Similar articles

Cited by

References

    1. Allderdice PW, Davis JG, Miller OJ, Klinger HP, Warburton D, Miller DA, Allen FH, Jr, Abrams CA, McGilvray E. The 13q-deletion syndrome. Am J Hum Genet. 1969;21:499–512. - PMC - PubMed
    1. Brown S, Gersen S, Anyane-Yeboa K, Warburton D. Preliminary definition of a "critical region" of chromosome 13 in q32: report of 14 cases with 13q deletions and review of the literature. Am J Med Genet. 1993;45:52–59. doi: 10.1002/ajmg.1320450115. - DOI - PubMed
    1. Brown S, Russo J, Chitayat D, Warburton D. The 13q- syndrome: the molecular definition of a critical deletion region in band 13q32. Am J Hum Genet. 1995;57:859–866. - PMC - PubMed
    1. Ballarati L, Rossi E, Bonati MT, Gimelli S, Maraschio P, Finelli P, Giglio S, Lapi E, Bedeschi MF, Guerneri S, et al. 13q Deletion and central nervous system anomalies: further insights from karyotype-phenotype analyses of 14 patients. J Med Genet. 2007;44:e60. doi: 10.1136/jmg.2006.043059. - DOI - PMC - PubMed
    1. Quelin C, Bendavid C, Dubourg C, de la Rochebrochard C, Lucas J, Henry C, Jaillard S, Loget P, Loeuillet L, Lacombe D, et al. Twelve new patients with 13q deletion syndrome: genotype-phenotype analyses in progress. Eur J Med Genet. 2009;52:41–46. doi: 10.1016/j.ejmg.2008.10.002. - DOI - PubMed

MeSH terms

Supplementary concepts

LinkOut - more resources